The unrecognized importance, danger and costs of hepatitis in the 21st century cannot be understated or underestimated. The impact of the disease on world society is highly significant and now presenting a major crisis in public health circles.
In his exhaustive analysis of the potential diagnosis, screening and therapeutic markets for hepatitis, Ken Krul, PhD. advises companies to think on a global basis. In this study, Global Hepatitis Strategies Krul examines the potential market, epidemiology (hepatitis patient trends) and technology to provide a clear understanding of the opportunities and challenges awaiting companies competing in this market.
As part of the market analysis this report includes
Global Hepatitis Treatment and Diagnostics
August 01, 2007
Or leave us a message and we'll call you back!
Receive bi-weekly email alerts for new market research.